Recognizing drug-induced liver injury: current problems, possible solutions (Q36086434)

12 August 2017

1 reference

title

Recognizing drug-induced liver injury: current problems, possible solutions (English)

1 reference

12 August 2017

William M Lee

1

1 reference

PubMed ID

15805067

12 August 2017

John R Senior

series ordinal

2

1 reference

PubMed ID

15805067

12 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

12 August 2017

Toxicologic Pathology

1 reference

12 August 2017

33

1 reference

12 August 2017

1

1 reference

12 August 2017

155-164

1 reference

Adverse drug event monitoring at the Food and Drug Administration

12 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post‐marketing setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

How safe is the safety paradigm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

Does proof of casualty ever exist in pharmacovigilance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

An efficient design for verifying disease outcome status in large cohorts with rare exposures and low disease rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

Using MedDRA: implications for risk management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

Causality assessment of drug-induced liver injury. Hepatology Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

NIH Director Elias A. Zerhouni, MD, reflects on agency's challenges, priorities. Interview by Catherine D. DeAngelis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

Attitudinal survey of voluntary reporting of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

Risk of unexplained acute liver failure in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

Troglitazone-induced liver failure: a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

Postmarketing surveillance for drug safety: surely we can do better

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

Criteria of drug-induced liver disorders. Report of an international consensus meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

The quality of published adverse drug event reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

Acute Liver Failure in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

Drug-induced hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

Troglitazone-induced hepatic failure leading to liver transplantation. A case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

An evaluation of adverse incident reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

Drug-Induced Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522356

10.1080/01926230590522356

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

15805067